In addition, in another study, it has been demonstrated that the PERK–ATF4 pathway may enhance the chemoresistance properties of colon cancer cells, which in a mouse model was found to inhibit the growth of colorectal cancer cells when PERK inhibitors were combined with 5‐FU [76]. This evidence concerns the gene EIF2AK3 and colonic neoplasm.